Heneka Nicole, Shaw Tim, Rowett Debra, Lapkin Samuel, Phillips Jane L
School of Nursing, University of Notre Dame Australia, Darlinghurst, New South Wales, Australia.
Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia.
BMJ Support Palliat Care. 2018 Jun;8(2):175-179. doi: 10.1136/bmjspcare-2017-001417. Epub 2018 Jan 4.
Opioids are a high-risk medicine frequently used to manage palliative patients' cancer-related pain and other symptoms. Despite the high volume of opioid use in inpatient palliative care services, and the potential for patient harm, few studies have focused on opioid errors in this population.
To (i) identify the number of opioid errors reported by inpatient palliative care services, (ii) identify reported opioid error characteristics and (iii) determine the impact of opioid errors on palliative patient outcomes.
A 24-month retrospective review of opioid errors reported in three inpatient palliative care services in one Australian state.
Of the 55 opioid errors identified, 84% reached the patient. Most errors involved morphine (35%) or hydromorphone (29%). Opioid administration errors accounted for 76% of reported opioid errors, largely due to omitted dose (33%) or wrong dose (24%) errors. Patients were more likely to receive a lower dose of opioid than ordered as a direct result of an opioid error (57%), with errors adversely impacting pain and/or symptom management in 42% of patients. Half (53%) of the affected patients required additional treatment and/or care as a direct consequence of the opioid error.
This retrospective review has provided valuable insights into the patterns and impact of opioid errors in inpatient palliative care services. Iatrogenic harm related to opioid underdosing errors contributed to palliative patients' unrelieved pain. Better understanding the factors that contribute to opioid errors and the role of safety culture in the palliative care service context warrants further investigation.
阿片类药物是一种高风险药物,常用于控制姑息治疗患者的癌症相关疼痛及其他症状。尽管住院姑息治疗服务中阿片类药物的使用量很大,且存在对患者造成伤害的可能性,但很少有研究关注该人群中的阿片类药物错误。
(i)确定住院姑息治疗服务报告的阿片类药物错误数量,(ii)确定报告的阿片类药物错误特征,以及(iii)确定阿片类药物错误对姑息治疗患者结局的影响。
对澳大利亚一个州的三家住院姑息治疗服务机构报告的阿片类药物错误进行为期24个月的回顾性审查。
在确定的55起阿片类药物错误中,84%影响到了患者。大多数错误涉及吗啡(35%)或氢吗啡酮(29%)。阿片类药物给药错误占报告的阿片类药物错误的76%,主要是由于漏服剂量(33%)或剂量错误(24%)。由于阿片类药物错误,患者更有可能接受比医嘱剂量低的阿片类药物(57%),42%的患者的错误对疼痛和/或症状管理产生了不利影响。一半(53%)的受影响患者因阿片类药物错误而需要额外的治疗和/或护理。
这项回顾性审查为住院姑息治疗服务中阿片类药物错误的模式和影响提供了有价值的见解。与阿片类药物剂量不足错误相关的医源性伤害导致姑息治疗患者的疼痛未得到缓解。进一步了解导致阿片类药物错误的因素以及安全文化在姑息治疗服务背景中的作用值得深入研究。